{"id":46916,"date":"2011-04-05T10:00:00","date_gmt":"2011-04-05T10:00:00","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=46916"},"modified":"2026-04-02T20:02:41","modified_gmt":"2026-04-02T20:02:41","slug":"companiile-preturile-si-promovarea-medicamentelor-analizate-de-concurenta","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=46916","title":{"rendered":"Companiile, preturile si promovarea medicamentelor, analizate de Concurenta"},"content":{"rendered":"<p>De asemenea, raportul cuprinde analize comparative ale<br \/>\npreturilor medicamentelor din Romania si mai multe state europene,<br \/>\nprecum si recomandari in ceea ce priveste promovarea in domeniul<br \/>\nfarmaceutic. &#8220;Desi pe piata romaneasca activeaza un numar important<br \/>\nde actori, tendinta acestei piete in ultimii ani a fost una de<br \/>\nconcentrare, primele 20 de companii controland aproximativ 78% din<br \/>\npiata. Aceasta concentrare s-a datorat in principal operatiunilor<br \/>\nde fuziuni si achizitii realizate la nivel international de<br \/>\ncompaniile care activeaza pe piata farmaceutica, dintre care cele<br \/>\nmai importante au fost achizitia Zentiva de catre Sanofi- Aventis,<br \/>\nachizitia Wyeth de catre Pfizer si achizitia Solvay de catre grupul<br \/>\nAbbott&#8221;, se arata in raportul publicat pe site-ul CC.<\/p>\n<p><a href=\"http:\/\/www.zf.ro\/companii\/companiile-preturile-si-promovarea-medicamentelor-analizate-de-concurenta-8130068\/\" target=\"_blank\">Cititi mai multe pe www.zf.ro<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Consiliul Concurentei (CC) a finalizat un raport despre piata de medicamente in care analizeaza principalii jucatori, atat din productie, import, cat si in distributie, dar si concurenta in aceasta industrie.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[511],"tags":[8256,8596,8088,323],"class_list":["post-46916","post","type-post","status-publish","format-standard","hentry","category-afaceri","tag-ancheta","tag-consiliul-concurentei","tag-farma","tag-medicamente"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/46916","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46916"}],"version-history":[{"count":2,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/46916\/revisions"}],"predecessor-version":[{"id":87545,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/46916\/revisions\/87545"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46916"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}